Asia Pacific High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, Hormonal Balance And Others) And By Region (Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023))

Asia Pacific High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, Hormonal Balance And Others) And By Region (Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023))

ID: 3027 | Pages: 145 | April 2018 | Region: Asia Pacific


Asia Pacific High Potency Active Pharmaceutical Ingredients Market was worth USD 4.14 billion in 2018 and estimated to be growing at a CAGR of 9.1%, to reach USD 6.39 billion by 2023. High Potency Active Pharmaceutical Ingredients (HPAPI) are a group of pharmacological substances and intermediates, active at concentrations of 150 micrograms per kilogram of body weight or below. They are characterised by high specificity, so they can bind to specific receptors or to specific enzymes which can cause cancer, reproductive problems  and developmental disorders at low doses. The growth of this market is high as many new drugs have these HPAPI’s.

High Potency Active Pharmaceutical Ingredients gave rise to alternative methods of treatment by different drugs, notably cancer. After the human genome mapping, new drugs for cancer could be made not only for different cancers but also for different patients. Their production is to be done with great care since they are active even at low concentrations. They can pose grave consequences to workers if proper care is not taken during production. Special care has to be taken to prevent contamination of drugs with contaminants. So it requires specialized equipment for handling HPAPI’s and managing air quality.

The Asia-Pacific High Potency Active Pharmaceutical Ingredients market has driving factors such as low price, growing government initiatives to increase the usage of generic medicines to cut down healthcare costs, growing healthcare prices, rising number of pharmaceutical manufacturers and patients. However the market is constrained by factors like lack of skilled workers, stringent regulatory requirements and high price of equipment.

The Asia-Pacific High Potency Active Pharmaceutical Ingredients market is segmented on the basis of type into innovative HPAPI’s and generic HPAPI’s. Innovative HPAPI’s has the largest market share due to factors like many number of them being patented, higher price as compared to generics, pharmaceutical manufacturers focusing on production of new drugs and demand for novel anti-cancer medicines. Based on synthesis, the market is divided into biotech HPAPI’s and synthetic HPAPI’s. Synthetic HPAPI’s have a larger market share due to rise of new drugs in the market, ease of production, technological improvements in synthesis and approval for the production of new drugs. Based on therapeutic application, the market is segmented into oncology, glaucoma, hormonal balance and others. Oncology has the largest share in the market. Factors such as rising incidence of cancer and launch of new target therapies is the reason for rise in the therapeutic segment.

The Asia-Pacific High Potency Active Pharmaceutical Ingredients market is geographically segmented into India, China, Australia, Thailand and other countries of Asia-Pacific. This region is expected to be the fastest growing region in the world. Factors such as increased funding into cancer research, rising number of people diagnosed with cancer and approval for the production of new drugs is going to boost the growth of this market in the region.

Some of the major players in the market include Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).

 

1.Introduction                                                               

               1.1 Market Definition                                                  

               1.2 Study Deliverables                                                 

               1.3 Base Currency, Base Year and Forecast Periods                                                         

               1.4 General Study Assumptions                                                

2. Research Methodology                                                                        

               2.1 Introduction                                             

               2.2 Research Phases                                                    

                              2.2.1 Secondary Research                                          

                              2.2.2 Primary Research                                

                              2.2.3 Econometric Modelling                                    

                              2.2.4 Expert Validation                                 

               2.3 Analysis Design                                                       

               2.4 Study Timeline                                                        

3. Overview                                                                   

               3.1 Executive Summary                                               

               3.2 Key Inferences                                                        

               3.3 Epidemology                                                           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                      

               4.1 Market Drivers                                                       

               4.2 Market Restraints                                                  

               4.3 Key Challenges                                                       

               4.4 Current Opportunities in the Market                                               

5. Market Segmentation                                                            

               5.1 Type                                                           

                              5.1.1 Innovative HPAPI's                              

                              5.1.2 Generic HPAPI's                                   

                              5.1.3  Y-o-Y Growth Analysis, By Type                                    

                              5.1.4  Market Attractiveness Analysis, By Type                                    

                              5.1.5  Market Share Analysis, By Type                                    

               5.2 Synthesis                                                   

                              5.2.1 Biotech HPAPI's                                   

                                             5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type               

                                                            5.2.1.1.1 Innovative Biotech HPAPIs         

                                                            5.2.1.1.2 Biosimilars       

                              5.2.2 Synthetic HPAPI's                                

                                             5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type              

                                                            5.2.2.1.1 Innovative Synthetic HPAPIs      

                                                            5.2.2.1.2 Generic Synthetic HPAPIs           

                              5.2.3 Y-o-Y Growth Analysis, By Synthesis                                            

                              5.2.4 Market Attractiveness Analysis, By Synthesis                                            

                              5.2.5 Market Share Analysis, By Synthesis                                            

               5.3 Therapeutic Application                                                      

                              5.3.1 Oncology                               

                              5.3.2 Glaucoma                              

                              5.3.3 Hormonal Balance                              

                              5.3.4 Other therapeutic applications                                      

                              5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application                                 

                              5.3.6  Market Attractiveness Analysis, By Therapeutic Application                               

                              5.3.7  Market Share Analysis, By Therapeutic Application                                

               5.4 Manufacturer                                                         

                              5.4.1 Captive Manufacturers                                     

                              5.4.2 Merchant Manufacturers                                 

                                             5.4.2.1 Merchant HPAPI Manufacturers Market, By Type                 

                                                            5.4.2.1.1 Innovative Merchant HPAPI Manufacturers         

                                                            5.4.2.1.2 Generic Merchant HPAPI Manufacturers              

                                             5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis                             

                                                            5.4.2.2.1 Synthetic HPAPIs           

                                                            5.4.2.2.2 Biotech HPAPIs              

                              5.4.3 Y-o-Y Growth Analysis, By Manufacturer                                    

                              5.4.4  Market Attractiveness Analysis, By Manufacturer                                  

                              5.4.5  Market Share Analysis, By Manufacturer                                   

6. Geographical Analysis                                                            

               6.1 Introduction                                             

                              6.1.1 Regional Trends                                   

                              6.1.2 Impact Analysis                                    

                              6.1.3 Y-o-Y Growth Analysis                                       

                                             6.1.3.1 By Type                

                                             6.1.3.2 By Synthesis                       

                                             6.1.3.3 By Therapeutic Application                           

                                             6.1.3.4 By Manufacturer               

                              6.1.4  Market Attractiveness Analysis                                     

                                             6.1.4.1 By Type                

                                             6.1.4.2 By Synthesis                       

                                             6.1.4.3 By Therapeutic Application                           

                                             6.1.4.4  By Manufacturer                             

                              6.1.5  Market Share Analysis                                      

                                             6.1.5.1 By Type                

                                             6.1.5.2 By Synthesis                       

                                             6.1.5.3 By Therapeutic Application                           

                                             6.1.5.4 By Manufacturer               

               6.2 China                                                         

               6.3 India                                                          

               6.4 Japan                                                         

               6.5 South Korea                                             

               6.6 Australia                                                   

7.Strategic Analysis                                                                     

               7.1 PESTLE analysis                                                      

                              7.1.1 Political                                  

                              7.1.2 Economic                               

                              7.1.3 Social                                      

                              7.1.4 Technological                                      

                              7.1.5 Legal                                       

                              7.1.6 Environmental                                     

               7.2 Porter’s Five analysis                                            

                              7.2.1 Bargaining Power of Suppliers                                       

                              7.2.2 Bargaining Power of Consumers                                   

                              7.2.3 Threat of New Entrants                                    

                              7.2.4 Threat of Substitute Products and Services                                

                              7.2.5 Competitive Rivalry within the Industry                                      

8.Market Leaders' Analysis                                                                       

               8.1 Pfizer Inc.                                                 

                              8.1.1 Overview                                

                              8.1.2 Product Analysis                                  

                              8.1.3 Financial analysis                                 

                              8.1.4 Recent Developments                                       

                              8.1.5 SWOT analysis                                     

                              8.1.6 Analyst View                                         

               8.2 Novartis International AG                                                   

               8.3 Sanofi                                                        

               8.4 F. Hoffmann-La Roche Ltd.                                                

               8.5 Eli Lilly and Company                                                           

               8.6 Bristol-Myers Squibb                                                            

               8.7 Boehringer Ingelheim                                                          

               8.8 Teva Pharmaceutical Industries Ltd.                                                

               8.9 Merck & Co., Inc.                                                   

               8.10 AbbVie Inc.                                                            

               8.11 Mylan Inc.                                              

9.Competitive Landscape                                                                         

               9.1 Market share analysis                                                          

               9.2 Merger and Acquisition Analysis                                                       

               9.3 Agreements, collaborations and Joint Ventures                                                         

               9.4 New Product Launches                                                        

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                        

               a) List of Tables                                              

               b) List of Figures                                            

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market By Type, From 2018-2023 ( USD Million )
  2. Asia-Pacific Innovative HPAPI's  Market By Region, From 2018-2023 ( USD Million )
  3. Asia-Pacific Generic HPAPI's Market By Region, From 2018-2023 ( USD Million )
  4. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2018-2023 ( USD Million )
  5. Asia-Pacific Biotech HPAPI's Market By Region, From 2018-2023 ( USD Million )
  6. Asia-Pacific Synthetic HPAPI's Market By Region, From 2018-2023 ( USD Million )
  7. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2018-2023 ( USD Million )
  8. Asia-Pacific Oncology Market By Region, From 2018-2023 ( USD Million )
  9. Asia-Pacific Glaucoma Market By Region, From 2018-2023 ( USD Million )
  10. Asia-Pacific Hormonal Balance Market By Region, From 2018-2023 ( USD Million )
  11. Asia-Pacific other therapeutic applications Market By Region, From 2018-2023 ( USD Million )
  12. Japan High Potency Active Pharmaceutical Ingredients Market By Type, From 2018-2023 ( USD Million )
  13. Japan High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2018-2023 ( USD Million )
  14. Japan High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2018-2023 ( USD Million )
  15. China High Potency Active Pharmaceutical Ingredients Market By Type, From 2018-2023 ( USD Million )
  16. China High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2018-2023 ( USD Million )
  17. China High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2018-2023 ( USD Million )
  18. India High Potency Active Pharmaceutical Ingredients Market By Type, From 2018-2023 ( USD Million )
  19. India High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2018-2023 ( USD Million )
  20. India High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2018-2023 ( USD Million )
  21. Australia High Potency Active Pharmaceutical Ingredients Market By Type, From 2018-2023 ( USD Million )
  22. Australia High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2018-2023 ( USD Million )
  23. Australia High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2018-2023 ( USD Million )
  24. South Korea High Potency Active Pharmaceutical Ingredients Market By Type, From 2018-2023 ( USD Million )
  25. South Korea High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2018-2023 ( USD Million )
  26. South Korea High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2018-2023 ( USD Million )
Middle East and Africa Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables...
Latin America Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Asia-Pacific Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrume...
Europe Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), ...
North America Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), End Use...
Middle East & Africa Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by...
Latin America Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techni...
Asia Pacific Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techniq...
Europe Cell Harvesting Systems Market By Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), By End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centers), By Techniques (B...
North America Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techni...
Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techniques (Blastome...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.